Pediatrix Medical Group, Inc. (MD) stock
MDNYSEServices-HospitalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/303% above fair value
$31.13−0.76 (-2.38%)
Close on Nov 17, 2026Market cap $2.43BP/E 16.9Yield –
Pediatrix Medical operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Pediatrix Medical's operating income for the twelve months ending Sep 30, 2026 was $212.58M, up 6.7% year over year. For fiscal 2025 it was $208.81M. Over ten years it grew -9.4% a year on average. The highest annual figure on record is $571.69M in fiscal 2016.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $208.81M | – |
| FY2024 | Dec 31, 2024 | -$68.71M | -1038.6% |
| FY2023 | Dec 31, 2023 | $7.32M | -95.8% |
| FY2022 | Dec 31, 2022 | $172.69M | -14.9% |
| FY2021 | Dec 31, 2021 | $202.92M | +106.8% |
| FY2020 | Dec 31, 2020 | $98.13M | -42.9% |
| FY2019 | Dec 31, 2019 | $171.76M | -30.9% |
| FY2018 | Dec 31, 2018 | $248.39M | -45.4% |
| FY2017 | Dec 31, 2017 | $454.89M | -20.4% |
| FY2016 | Dec 31, 2016 | $571.69M | +2.5% |
| FY2015 | Dec 31, 2015 | $557.87M | +8.7% |
| FY2014 | Dec 31, 2014 | $513.00M | +13.5% |
| FY2013 | Dec 31, 2013 | $452.13M | +16.1% |
| FY2012 | Dec 31, 2012 | $389.52M | +9.6% |
| FY2011 | Dec 31, 2011 | $355.39M | +13.6% |
| FY2010 | Dec 31, 2010 | $312.91M | +8.3% |
| FY2009 | Dec 31, 2009 | $288.93M | +19.4% |
| FY2008 | Dec 31, 2008 | $242.03M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $65.21M | -4.2% |
| Q2 FY2026 | Jun 30, 2026 | $56.92M | -4.9% |
| Q1 FY2026 | Mar 31, 2026 | $41.66M | +29.8% |
| Q4 FY2025 | Dec 31, 2025 | $48.79M | +24.2% |
| Q3 FY2025 | Sep 30, 2025 | $68.05M | +101.2% |
| Q2 FY2025 | Jun 30, 2025 | $59.87M | – |
| Q1 FY2025 | Mar 31, 2025 | $32.10M | +102.0% |
| Q4 FY2024 | Dec 31, 2024 | $39.29M | – |
| Q3 FY2024 | Sep 30, 2024 | $33.83M | -16.0% |
| Q2 FY2024 | Jun 30, 2024 | -$157.72M | -425.2% |
| Q1 FY2024 | Mar 31, 2024 | $15.89M | -47.1% |
| Q4 FY2023 | Dec 31, 2023 | -$111.49M | -409.4% |
| Q3 FY2023 | Sep 30, 2023 | $40.27M | -15.0% |
| Q2 FY2023 | Jun 30, 2023 | $48.50M | -3.3% |
| Q1 FY2023 | Mar 31, 2023 | $30.04M | -23.2% |
| Q4 FY2022 | Dec 31, 2022 | $36.04M | -47.0% |
| Q3 FY2022 | Sep 30, 2022 | $47.39M | -19.4% |
| Q2 FY2022 | Jun 30, 2022 | $50.16M | +0.3% |
| Q1 FY2022 | Mar 31, 2022 | $39.11M | +49.8% |
| Q4 FY2021 | Dec 31, 2021 | $68.01M | +110.5% |
| Q3 FY2021 | Sep 30, 2021 | $58.79M | +187.4% |
| Q2 FY2021 | Jun 30, 2021 | $50.02M | +44.7% |
| Q1 FY2021 | Mar 31, 2021 | $26.10M | +141.6% |
| Q4 FY2020 | Dec 31, 2020 | $32.31M | -19.5% |
| Q3 FY2020 | Sep 30, 2020 | $20.46M | -57.9% |
| Q2 FY2020 | Jun 30, 2020 | $34.57M | -19.7% |
| Q1 FY2020 | Mar 31, 2020 | $10.80M | -73.0% |
| Q4 FY2019 | Dec 31, 2019 | $40.14M | -62.0% |
| Q3 FY2019 | Sep 30, 2019 | $48.57M | -53.4% |
| Q2 FY2019 | Jun 30, 2019 | $43.06M | -64.8% |
| Q1 FY2019 | Mar 31, 2019 | $39.99M | -59.9% |
| Q4 FY2018 | Dec 31, 2018 | $105.55M | -16.0% |
| Q3 FY2018 | Sep 30, 2018 | $104.21M | -17.6% |
| Q2 FY2018 | Jun 30, 2018 | $122.39M | +0.4% |
| Q1 FY2018 | Mar 31, 2018 | $99.66M | -6.0% |
| Q4 FY2017 | Dec 31, 2017 | $125.70M | -12.0% |
| Q3 FY2017 | Sep 30, 2017 | $126.43M | – |
| Q2 FY2017 | Jun 30, 2017 | $121.90M | – |
| Q1 FY2017 | Mar 31, 2017 | $106.04M | – |
| Q4 FY2016 | Dec 31, 2016 | $142.78M | – |
See a number that looks wrong?